Related Experiment Video
Updated: Jun 13, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Vascular calcification in chronic kidney disease
Adrian Covic1, Mehmet Kanbay, Luminita Voroneanu
1Clinic of Nephrology, C. I. Parhon University Hospital, Gr. T. Popa University of Medicine and Pharmacy, Bd. Carol I, Nr. 50, Iasi, Romania. adrianccovic@gmail.com
Insights
Vascular calcification (VC) is common in chronic kidney disease (CKD) due to complex factors. Understanding VC mechanisms and inhibitors is crucial for developing new treatments to improve cardiovascular outcomes in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Vascular calcification (VC) is highly prevalent in chronic kidney disease (CKD) patients.
- Pathogenesis involves traditional and non-traditional cardiovascular risk factors, including dialysis duration and mineral metabolism disorders.
- Key mechanisms include vascular smooth muscle cell transformation and impaired regulation of inhibitors.
Purpose of the Study:
- To review the pathophysiological mechanisms, detection methods, and management strategies for VC in CKD.
- To highlight the role of non-traditional risk factors and VC inhibitors.
- To inform the development of novel therapeutic agents for reducing VC and improving cardiovascular outcomes.
Main Methods:
- Literature review of pathophysiological mechanisms of VC in CKD.
- Summary of current methods for VC detection, including arterial stiffness evaluation.
- Overview of existing and potential management strategies for VC.
Main Results:
- VC pathogenesis is multifactorial, involving mineral metabolism disorders and altered cell phenotypes.
- VC contributes significantly to increased arterial stiffness, left ventricular hypertrophy, and cardiovascular mortality in CKD.
- Current treatments focus on mineral and bone disorder management, but novel agents targeting VC mechanisms are needed.
Conclusions:
- VC is a major contributor to cardiovascular morbidity and mortality in CKD patients.
- A comprehensive understanding of VC mechanisms, promoters, and inhibitors is essential for therapeutic advancements.
- Future research should focus on developing targeted therapies to mitigate VC and improve cardiovascular health in CKD.
Abstract:
VC (vascular calcification) is highly prevalent in patients with CKD (chronic kidney disease), but its mechanism is multifactorial and incompletely understood. In addition to increased traditional risk factors, CKD patients also have a number of non-traditional cardiovascular risk factors, which may play a prominent role in the pathogenesis of arterial calcification, such as duration of dialysis and disorders of mineral metabolism. The transformation of vascular smooth muscle cells into chondrocytes or osteoblast-like cells seems to be a key element in VC pathogenesis, in the context of passive calcium and phosphate deposition due to abnormal bone metabolism and impaired renal excretion. The process may be favoured by the low levels of circulating and locally produced VC inhibitors. VC determines increased arterial stiffness, left ventricular hypertrophy, a decrease in coronary artery perfusion, myocardial ischaemia and increased cardiovascular morbidity and mortality. Although current therapeutic strategies focus on the correction of phosphate, calcium, parathyroid hormone or vitamin D, a better understanding of the mechanisms of abnormal tissue calcification may lead to development of new therapeutic agents, which could reduce VC and improve cardiovascular outcome in CKD patients. The present review summarizes the following aspects: (i) the pathophysiological mechanism responsible for VC and its promoters and inhibitors, (ii) the methods for detection of VC in patients with CKD, including evaluation of arterial stiffness, and (iii) the management of VC in CKD patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Skeleton and Calcium Homeostasis
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

